The pull-back is to be expected given the $3.5M CR @17c in Dec21. Some Sophs may be keen to cash in on gains given market uncertainties. And while we've got great newsflow coming, there's still a way to go with toxicity tests (all indications are good) and regulatory hurdles for some key verticals. US patent approval and the 9-month grain storage efficacy study are major milestones on the journey to commercialisation. If you're losing faith, read more @stevenjd, the Biogene muse. GLTAH R-7
Ann: Positive Stored Grain Pest Results, page-40
Add BGT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $11.07M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 9952 | 5.3¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.4¢ | 540 | 1 |
View Market Depth
| Last trade - 16.12pm 07/11/2024 (20 minute delay) ? |
| BGT (ASX) Chart |
Day chart unavailable